Strides Pharma Science arm gets USFDA EIR for Alathur facility Ruchika Sharma20 Aug 2024 11:25 AM ISTBengaluru: Strides Alathur Private Limited, a wholly-owned subsidiary of Strides Pharma Science Limited has received an Establishment Inspection...
CDSCO Panel Approves AstraZeneca's protocol amendment proposal for COPD drug Tozorakimab Dr. Divya Colin19 Aug 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
AstraZeneca gets USD 107 million Pfizer verdict overturned in US cancer drug patent fight Ruchika Sharma19 Aug 2024 4:45 PM ISTCambridge: AstraZeneca has convinced a Delaware federal judge to throw out a jury's decision that the company owes USD 107.5 million for...
USFDA grants marketing authorization for First To Know Syphilis Test for OTC use Ruchika Sharma19 Aug 2024 4:00 PM ISTSpringdale: NOWDiagnostics, Inc., a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, has announced that the U.S....
MSN Laboratories gets CDSCO Panel nod to conduct Bioequivalence Study of Abiraterone Tablets1000mg Dr. Divya Colin18 Aug 2024 5:45 PM ISTNew Delhi: MSN Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
India's medicine, antibiotics exports gaining share in US, Italian markets: Govt Ruchika Sharma18 Aug 2024 1:15 PM ISTNew Delhi: As the government emphasizes enhancing domestic pharmaceutical manufacturing, India's exports of medicines and antibiotics have begun...
ANVISA-Brazil concludes inspection at Caplin Steriles Gummidipoondi facility with zero observations Ruchika Sharma18 Aug 2024 12:30 PM ISTChennai: Caplin Point Laboratories Limited has informed that ANVISA-Brazil concluded an inspection at Caplin Steriles' injectable and ophthalmic...
Imfinzi, Lynparza combo approved in EU for mismatch repair proficient advanced or recurrent endometrial cancer: AstraZeneca Ruchika Sharma18 Aug 2024 10:00 AM ISTCambridge: AstraZeneca's Imfinzi (durvalumab) and Lynparza (olaparib) have been approved in the European Union (EU) as treatment for certain...
USFDA grants accelerated approval to Gilead Sciences Livdelzi for Primary Biliary Cholangitis Ruchika Sharma17 Aug 2024 3:30 PM ISTFoster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi...
AstraZeneca Imfinzi in combo with chemotherapy gets USFDA approval for treatment of resectable non-small cell lung cancer before and after surgery Ruchika Sharma17 Aug 2024 1:30 PM ISTCambridge: AstraZeneca's Imfinzi (durvalumab) in combination with chemotherapy has been approved in the US for the treatment of adult...
Lupin secures USFDA tentative nod for Brimonidine Tartrate Ophthalmic Solution Ruchika Sharma17 Aug 2024 11:33 AM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United States Food and Drug...
Sun Pharma to buy over 5 percent stake in Pharmazz for up to USD 15 million Ruchika Sharma17 Aug 2024 10:00 AM ISTMumbai: Sun Pharmaceutical Industries Limited has entered into an agreement with Pharmazz Inc. Delaware US, pursuant to which the Company has...
